Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 1999, p. 2913-2919, Vol. 37, No. 9
Department of Food Science and Technology,
Received 20 January 1999/Returned for modification 26 April
1999/Accepted 25 May 1999
The sequence of the rpoB gene from Listeria
monocytogenes was determined. Rifampin-resistant
(Rifr) mutants arising from L. monocytogenes cultures exposed to rifampin were isolated, and by
partial sequencing of their rpoB genes, seven different
point mutations affecting five different amino acids (473Asp Listeria monocytogenes is
a facultative intracellular pathogen; its ability to become
internalized by and survive inside macrophages and epithelial cells is
crucial for sustaining a systemic infection (11). After
infection, L. monocytogenes can directly infect neighboring
cells within a tissue at sites of plasma membrane contact, thus
avoiding exposure to host extracellular defenses (9).
L. monocytogenes possesses at least three multicomponent systems which are essential for survival in the host: virulence factors
(23), defense mechanisms against reactive oxygen
metabolites, and environmental stress proteins (14). The
virulence factors are controlled by a common regulatory gene,
prfA (8), and by environmental signals
(18). L. monocytogenes also requires stress proteins at some stage of the infection, because mutants unable to
induce an acid tolerance response display diminished virulence in
murine models (16), while acid-tolerant mutants demonstrate increased virulence (20).
Rifampin is a derivative of the rifamycins, a class of antibiotics that
are secondary metabolites of Nocardia mediterranei (30). Rifampin has a wide antibacterial spectrum and low
MICs, especially for gram-positive organisms. Its mechanism of action is to inhibit DNA-dependent RNA polymerase (RNAP) enzymatic activity, this inhibition being specific to prokaryotes. Rifampin and RNAP form a
tight complex in which one molecule of antibiotic is bound to one
enzyme molecule. Rifampin resistance (Rifr) can be
caused by alteration of the target site in the As antibiotic use in the food and agriculture industry increases,
particularly the use of rifampin to control food-poisoning organisms
such as L. monocytogenes, there may well be a concomitant increase in resistant strains, since a mutation at a single site can
cause resistance. It is therefore important to identify these mutation
sites, the rates at which mutations occur at them, and the subsequent
phenotypes generated. In this study, Rifr strains of
the food-borne pathogen L. monocytogenes were isolated and
characterized by sequencing, and their resistance to heat shock and
interactions with a mammalian cell line were tested.
Isolation of Rifr mutants.
L.
monocytogenes NCTC 7973 was used in this study. Cultures were
grown in Mueller-Hinton broth (Oxoid, Basingstoke, United Kingdom) to a
cell density of approximately 109/ml and then concentrated
by centrifugation to approximately 1011 cells/ml. Then 160 µl was spread onto Mueller-Hinton agar plates containing 0.007 µg
of rifampin (Sigma, Poole, United Kingdom) per ml and incubated at
37°C for 17 h. Single colonies were selected for further analysis.
MIC determination.
MICs were determined by inoculating 100 µl of a stationary-phase culture (105 to 106
cells) into 10 ml of Mueller-Hinton broth containing rifampin at
concentrations ranging from 0.001 to 100 µg/ml.
Growth curves.
A 100-µl inoculum of each
Rifr mutant and the wild-type strain was grown in 10 ml of coryneform broth containing (liter Immunofluorescence assay.
Caco-2 cells were cultured and
maintained by methods previously described (28). Bacterial
adhesion was measured by an immunofluorescence assay, also as
previously described (28), with the exception of the use of
Bacto-Listeria O Antisera Types 1,4 (Difco Laboratories, East Molsley,
United Kingdom) to detect L. monocytogenes.
PCR amplification.
Chromosomal DNA was extracted by a
modified version of the method described by Lawson et al.
(15). Primers were synthesized as Ready Pure
oligonucleotides by Applied Biosystems (Warrington, United Kingdom),
diluted to stock concentrations of 200 ng/µl (for PCRs) and 20 ng/µl (for sequencing reactions). A complete copy of the
rpoB gene together with an upstream region was generated from L. monocytogenes as two overlapping PCR products with
primer pairs 1475 [GA(A/G)AA(A/G)ACNGA(A/G)TT(T/C)GA(T/C)GT,
3' end of rplL] and 2428 [GCCCANAC(C/T)TCCAT(C/T)TCNCC, 3'
end of rpoB gene] and 2233 [GTNTT(T/C)ATGGGNGA(T/C)TT(T/C)CC, 5' end of rpoB
gene] and 1919 [AC(A/G)TAN(C/G)(A/G)AA(A/G)TANAT, 5' end of
rpoC gene]. PCRs were performed in 1× PCR buffer
(Perkin-Elmer, Warrington, United Kingdom) containing 10 mM
deoxynucleotide triphosphates and 4 ng of each oligonucleotide primer
per ml in a final volume of 50 µl under a layer of PCR-grade mineral
oil (Sigma) by using a Biometra (Maidstone, United Kingdom) PCR thermal
cycler. After an initial denaturation step of 94°C for 5 min,
AmpliTaq polymerase (Perkin-Elmer) was added to a final concentration
of 0.02 U/µl, and 25 cycles of 92°C for 1 min, 48°C for 1 min,
and 65°C for 3 min were performed, ending with a final extension step
of 65°C for 10 min.
Cloning, transformation, and sequencing.
PCR products were
purified with a QIAquick PCR purification kit (Qiagen, Dorking, United
Kingdom), ligated into pCRII vector (TA cloning kit; Invitrogen,
Abingdon, United Kingdom), and transformed into E. coli
INV Nucleotide sequence accession number.
The L. monocytogenes rpoB gene sequence described here has been deposited
in the EMBL database under the accession no. Y16468.
Nucleotide sequence of the rpoB gene and part of the
rplL-rpoB intergenic space in L. monocytogenes
NCTC 7973.
The complete sequence of the rpoB gene was
determined together with 1,814 bp of upstream DNA sequence from
L. monocytogenes NCTC 7973. The rpoB gene codes
for a MIC and isolation of Rifr mutants.
Rifr mutants were isolated at a frequency of
approximately 10
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Isolation of Rifampin-Resistant Mutants of
Listeria monocytogenes and Their Characterization by
rpoB Gene Sequencing, Temperature Sensitivity for Growth,
and Interaction with an Epithelial Cell Line
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Asn or
Gly, 479Gly
Asp, 483His
Tyr or Leu, 528Ile
Phe, and
530Ser
Tyr), which led to MICs of 0.5 to 100 µg/ml for the organisms, were determined. These mutants showed various deficiencies for growth at 42°C, with only one being comparable to the wild-type strain. The interaction of these Rifr mutants with
human Caco-2 cells was examined by using an immunofluorescence technique. Three mutants failed to interact, while three showed a
reduced interaction compared to that of the wild type. It is believed
that these pleiotropic phenotypes have arisen as a result of mutations
within the DNA-dependent RNA polymerase holoenzyme.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
subunit of RNAP
(30), and sequencing of the rpoB gene, which
codes for the
subunit, from Rifr
Escherichia coli mutants revealed that more than 90% of the
Rifr mutations are located in a region encompassing
amino acid residues 505 to 532, with most of the remainder being
located in a region comprising amino acid residues 560 to 572. Other
possible mechanisms of resistance include a reduction in the ability of
the antibiotic to enter the bacterium due to alterations in the
structure of the outer membrane, as is the case for a number of
mycobacteria (7), while certain Nocardia spp.,
Mycobacterium spp., and Pseudomonas aeruginosa
strains have been shown to modify rifampin by ribosylation and
glucosylation at the 23-OH group of the antibiotic (22, 25,
26). It has been shown that Rifr mutations can
be pleiotropic in some organisms, conferring altered phenotypes. For
example, certain Rifr mutants of
Staphylococcus aureus, Francisella tularensis,
and Mycobacterium leprae all show a reduced pathogenicity in
animal models together with a temperature sensitivity for growth
(3, 17, 19).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
1) 10 g of
tryptone (Oxoid), 5 g of yeast extract (Oxoid), and 5 g of
glucose (Sigma) in a 30-ml Sterilin universal container, and rifampin
was added to each vessel at the highest subinhibitory concentration
applicable for each mutant. The cultures were shaken at 100 rpm for
17 h at 37°C. Then 500 µl of each culture was inoculated in
duplicate into 50 ml of coryneform broth, kept in 100-ml glass Duran
bottles containing rifampin, also at the highest subinhibitory concentration, and was shaken at 100 rpm in 37 and 42°C waterbaths. The optical density at 600 nm of 0.8-ml aliquots of each culture were
measured at hourly intervals for 24 h and plotted. This was repeated four times and the mean optical density values were plotted.
I cells according to the manufacturer's instructions. DNA
sequencing was performed by using the dideoxynucleotide chain termination method on both positive and negative strands of each cloned
PCR product. Two independent PCR products were sequenced for the wild
type and each mutant rpoB gene, with a third PCR product
being generated to resolve any nucleotide base discrepancies. On
average, one nucleotide base error was detected for every 3 kb of
determined sequence. Sequences were aligned by using the PILEUP program
from the Wisconsin Molecular Biology software package (10),
and the multiple alignments were checked manually.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
subunit of 1,387 amino acids which shows a number of
deletions and insertions in comparison with the E. coli
subunit (Fig. 1). Unlike the
rpoB gene from E. coli but similar to those from
Bacillus subtilis and S. aureus, the L. monocytogenes rpoB gene possesses a promoter sequence. The
upstream sequence contains an open reading frame coding for a protein
of 392 amino acids and a molecular mass of approximately 43,565 Da
(data not shown). This open reading frame is 510 bp upstream from the
rpoB gene and has a putative promoter sequence at positions
19 and
36, a ribosome binding site at position
7, and an ATG
start codon.

View larger version (68K):
[in a new window]
FIG. 1.
Alignment of the amino acid sequences encoded by the
rpoB genes of L. monocytogenes (LM) and E. coli (EC).
9. The MICs for 24 mutants were
determined and ranged from 0.5 to 100 µg/ml (Table
1).
TABLE 1.
MIC, mutation position, and amino acid alteration in the
subunit and base alteration in the rpoB gene resulting
in rifampin resistance in L. monocytogenes
Sequence determination of part of the rpoB gene from 24 Rifr mutants. The 24 mutants were further characterized by partial sequencing of their rpoB genes. Oligonucleotides were designed to generate regions of the rpoB gene from the Rifr mutants that were homologous to the Rifr clusters of E. coli. Sequence analysis revealed that 9 of the 24 mutants had base alterations in these regions, with seven different mutations being identified (Table 1). The remaining 15 mutants contained no mutations in the regions sequenced, and no further work was carried out on these mutants. All mutants were subjected to 16S rRNA gene sequencing analysis, and their taxonomic identities were confirmed.
Comparison of the growth rates of the characterized Rifr mutants and the wild-type strain, grown at 37 and 42°C. Growth rates for the mutant and wild-type strains were similar when the organisms were cultured at 37°C for 24 h (data not shown). All strains reached an optical density at 600 nm of 0.8, which is a density range of approximately 7 × 108 to 2 × 109 cells/ml. Wild-type and mutant strains cultured in parallel were simultaneously grown for 24 h at 42°C (Fig. 2). Mutants 5, 7 (not shown in Fig. 2, as its growth pattern is identical to that of mutant 8), 8, and 23 demonstrated little or no growth even after 22 h (Fig. 2). Mutants 6 and 17 showed an unusual pattern of growth, with very little growth occurring until 18 h, after which rapid growth occurred; in the case of mutant 6, growth exceeded that of the wild-type strain. To demonstrate that this growth was not due to contamination, a sample was taken and found by both plating on selective media and 16S rRNA gene sequence determination to contain only L. monocytogenes (data not shown). Upon reincubation at 42°C, these isolates performed identically to the wild-type strain (data not shown).
|
Comparison of the association of L. monocytogenes wild-type and Rifr mutants with Caco-2 cells. Figure 3a to i show images of the Caco-2 cells 1 h after exposure to L. monocytogenes wild-type and mutant strains. As can be seen, the wild-type strain (Fig. 3a) demonstrated the greatest degree of attachment, while mutant strains 8, 14, and 22 (Fig. 3e, f, and b, respectively) possessed similar Caco-2 interaction phenotypes. The weakest interaction was shown by mutants 5, 6, and 23 (Fig. 3h, g, and d, respectively). Mutants 7 and 8, having mutations which map to the same position (amino acid 473), showed similar phenotypic responses to elevated temperature stress and the MICs for them were similar (Table 1 and Fig. 2), and yet these mutants had remarkably different interactions with Caco-2 cells (Fig. 3i and e, respectively). In addition, mutant 8 caused cytopathic damage, as evidenced by large gaps in the monolayer, which are visible as dark areas in Fig. 3e. The lack of bacterial attachment to the exposed vessel in these areas demonstrates the specificity of bacterial adhesion to Caco-2 cells. Whether the invasiveness of mutant 8 is significantly increased to cause lysis of the monolayer in this way is unknown. As expected, mutants 6 and 17 (Fig. 3g and j, respectively) showed only small differences in their ability to interact with Caco-2 cells because these mutants possess identical Rifr mutations. Mutant 14 is most interesting as it appears to have a more coccoid morphology than any of the other strains examined, yet its ability to interact with Caco-2 cells is similar to that of the wild-type strain (Fig. 3f).
|
| |
DISCUSSION |
|---|
|
|
|---|
The objectives of this work were to identify naturally occurring Rifr mutations in L. monocytogenes, to compare these mutations to those found in other bacteria to gain further insight into the mechanisms of action of rifampin, and to identify phenotypic changes that occur as a result of such mutations.
The extremely low MIC for wild-type L. monocytogenes was
consistent with earlier low rifampin MICs for gram-positive organisms and is probably due to the great permeability of the outer membrane to
rifampin rather than to the RNAP of this bacterium being hypersensitive (30). In a previous study, the MIC range for L. monocytogenes strains isolated from adult patients being treated
for meningitis or septicemia was 0.06 to 0.12 µg/ml, and
rifampin-resistant mutants in vitro arose at a frequency of
approximately 10
7, although these mutants were not
characterized further (5). However, in the present study
naturally occurring Rifr mutants arose at a
frequency of approximately 10
9. High-level resistance to
rifampin may result from the reduced ability of rifampin to bind
strongly to a polar amino acid which has replaced a nonpolar amino
acid, as the physical nature of bonds involved in the rifampin-RNAP
complex seems to be mainly lipophilic (30). This was
supported in this study by mutant 20, where a change from a nonpolar
glycine to a polar aspartate yielded the highest MIC, 100 µg/ml.
Steric hindrance may also have an effect in the proposed direct binding
site of rifampin. For example, mutants 22 and 23 both have mutations
located at position 483 and yet these mutations result in two
distinctly different amino acids. Mutant 22 has a change from a polar
histidine to a polar tyrosine, which is a large amino acid with a large phenolic side chain. It is possible that the MIC for this mutant is
high not only due to the location of the mutation in the rifampin binding site but also as a result of the steric hindrance which occurs
because of the alteration. An identical His-to-Tyr mutation at the
equivalent position in the
subunit of S. aureus also produces a high MIC (1). In mutant 23, leucine, a small
nonpolar amino acid, replaces histidine at the same position. Although this mutation also resulted in Rifr, the MIC was
much lower than that for mutant 22, possibly because leucine is similar
in size and hydrophobicity to histidine and therefore is still able to
bind rifampin, although to a lesser degree. The MICs for mutants 7 and
8, containing identical rpoB mutations, are slightly
different (Table 1). Identical mutations that occur at the equivalent
positions in the
subunits of S. aureus and
Neisseria meningitidis also yield variations in MIC (1,
7). As rifampin is hydrophobic in nature, a second mutation may
have reduced the ability of the antibiotic to enter the bacteria due to
alteration of the structure of the outer membrane.
The amino acid sequence of the
subunit from L. monocytogenes was compared to that of E. coli (Fig. 1).
In all, the characterized mutations affected five different amino
acids, and consistent with findings in other species, most mapped to a
region corresponding to that between positions 516 and 526 on the
E. coli
subunit. Mutants 22 and 23 showed different base
changes, but these changes mapped to a codon homologous to the
often-reported site of Rifr, amino acid position
526, in E. coli. However, a mutation was mapped to position
530 on the L. monocytogenes
subunit, the equivalent of which has not been found in any other species
to date (Table 1). Also, a number of base alterations resulting in
amino acid changes which have not been reported elsewhere were observed
in L. monocytogenes. For example, the mutations in mutants 7, 8, and 5 mapped to position 473, a highly conserved asparagine residue where mutations have previously been found in
Rifr Mycobacterium tuberculosis and
E. coli. However, the GAT
GGT point mutation shown
by mutant 5 has not been found in any other organism to date at this
position. In total, seven different mutations were identified in this study.
The majority of the Rifr mutants isolated show a
temperature sensitivity when grown at 42°C. Studies on growth
phenotypes of Rifr mutants of E. coli
mapped elevated temperature sensitivity to changes in amino acids 522 to 529. It has been proposed that mutations in this region result in a
conformational change in the structure of the enzyme leading to
improper folding or functioning at temperature extremes
(13). Alternatively, this region may interact with the sigma
factors required for growth at high temperatures (32). The
present findings indicate that mutations affecting amino acid 473 have
the most adverse affect on the organism when it is grown at 42°C.
Therefore, it is possible that the asparagine at position 473 is
important for sigma factor binding. It has recently been shown, using a
70-conjugated chemical protease, that the core binding
region of this sigma factor (conserved region 3.1) in E. coli binds to the methionine at position 515, equivalent to the
methionine at position 472 in L. monocytogenes
(21).
The reversion of mutants 6 and 17 to wild-type growth at 42°C is probably due to a secondary mutation. As rifampin was maintained at an inhibitory concentration in all culturing work involving the Rifr mutants, this is unlikely to be a reversion of the rifampin resistance mutation but rather a secondary mutation that compensates for growth at 42°C while still maintaining Rifr. Such secondary mutations have been previously described for antibiotic-resistant strains of Salmonella typhimurium (4). The nature of these secondary mutations needs to be addressed.
There may not necessarily be a relation between the ability to grow at
elevated temperatures and reduction in macrophage survival, unless the
altered RNAP holoenzyme is unable to bind a sigma factor responsible
for transcribing genes required for both growth at elevated
temperatures and survival within host cells. For example, the
alternative sigma factor
B in L. monocytogenes has been shown to coordinate the response to high
osmotic stress (2), and yet
B null mutants,
although having a reduced acid tolerance, do not show a reduction in
virulence (31). No increase in virulence has previously been
reported for bacteria containing mutations in the rpoB gene,
and yet mutants 8, 14, and 22, whose mutations are located at positions
473, 528, and 483, respectively, showed a degree of interaction with
Caco-2 cells that was similar to or greater than that of the wild type
(Fig. 3e, f, and b, respectively). Alterations of the RNAP core enzyme
in these mutants may enhance the binding of sigma factors required for
transcription of virulence genes. The phenotypes of these mutants could
be expected to be similar to the enhanced virulence of mutants that
constitutively overexpress PrfA (24).
It has been shown (12) that L. monocytogenes possesses a protein, internalin A (coded for by the inlA gene), that is required for binding to and entry into Caco-2 cells. As mutants 5, 6, and 23 were not observed attached to or internalized in the Caco-2 cells, it is possible that expression of this protein is defective in these mutants. A recent work correlating Caco-2 cell tissue culture assays with the virulence of L. monocytogenes (27) indicates that our mutants 5, 6, and 23 may well be avirulent.
Mutant 14 (Fig. 3f) demonstrates an unusual coccoid morphology. It has
been previously reported that a mutation at the carboxyl terminus of
the
subunit of E. coli causes the overexpression of a
protein, FtsZ, which plays a central role in regulating the timing and
frequency of septum formation (6). Increased activity appears to occur at a
S-dependent promoter upstream from
the ftsZ gene, indicating that the mutant form of the
subunit may have an increased affinity for
S, a
stationary-phase sigma factor. This overexpression of FtsZ has the
effect of producing minicells (29) similar to those observed
for mutant 14. Although the mutation causing this effect in E. coli occurs at position 1329 at the carboxyl terminus of the
subunit, whereas that in mutant 14 occurs at position 528, it is still
plausible that the L. monocytogenes mutant
subunit has
an enhanced affinity for a homologue of the E. coli
S and hence affects cell division in a similar way.
Again, as with the MIC data, even though mutants 7 and 8 contain
identical rpoB mutations, they showed slightly different
properties of binding to Caco-2 cells; this indicates that a second
mutation may have occurred in one of the mutants during the one-step
selection procedure, which may be present either in a part of the
rpoB gene not sequenced in this study or elsewhere on the genome.
The ability of rifampin to penetrate host cells could become particularly important for the treatment of listeriosis, since L. monocytogenes is known to remain intracellular and spread from cell to cell by an actin-based motility process (12). Because antibiotic resistance in agriculture is a growing problem, it will be increasingly important to identify mutant organisms, their genotypes, and their altered phenotypes in order to understand their dissemination.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the Biotechnology and Biological Sciences Research Council and by grant BIO2-CT94-3098 from the European Community.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Food Science and Technology, The University of Reading, Whiteknights, P.O. Box 226, Reading RG6 6AP, United Kingdom. Phone: 44-118-9357228. Fax: 44-118-9267917. E-mail: robert.morse{at}bbsrc.ac.uk.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Aubry-Damon, H.,
C.-J. Soussy, and P. Courvalin.
1998.
Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus.
Antimicrob. Agents Chemother.
42:2590-2594 |
| 2. |
Becker, L. A.,
M. S. Cetin,
R. W. Hutkins, and A. K. Benson.
1998.
Identification of the gene encoding the alternative sigma factor B from Listeria monocytogenes and its role in osmotolerance.
J. Bacteriol.
180:4547-4554 |
| 3. | Bhatnager, N., E. Getachew, S. Straley, J. Williams, M. Meltzer, and A. Fortier. 1994. Reduced virulence of rifampin-resistant mutants of Francisella tularensis. J. Infect. Dis. 170:841-847[Medline]. |
| 4. | Bjorkman, J., D. Hughes, and D. L. Andersson. 1998. Virulence of antibiotic-resistant Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 95:3939-3953. |
| 5. | Boisivon, A., C. Guiomar, and C. Carbon. 1990. In vitro bactericidal activity of amoxicillin, gentamicin, rifampin, ciprofloxacin and trimethoprim-sulfamethoxazole alone or in combination against Listeria monocytogenes. Eur. J. Clin. Microbiol. Infect. Dis. 9:206-209[Medline]. |
| 6. |
Cam, K.,
A. Cuzange, and J. P. Bouché.
1995.
S-dependent overexpression of ftsZ in an Escherichia coli K12 rpoB mutant that is resistant to the division inhibitors DicB and DicF RNA.
Mol. Gen. Genet.
248:190-194[Medline].
|
| 7. |
Carter, P. E.,
F. J. R. Abadi,
D. E. Yakuba, and T. H. Pennington.
1994.
Molecular characterization of rifampin-resistant Neisseria meningitidis.
Antimicrob. Agents Chemother.
38:1256-1261 |
| 8. |
Chakraborty, T.,
M. Leimeister-Wachter,
E. Domann,
M. Hartl,
W. Goebel,
T. Nichterlein, and S. Notermans.
1992.
Coordinate regulation of virulence genes in Listeria monocytogenes requires the product of the prfA gene.
J. Bacteriol.
174:568-574 |
| 9. | Cossart, P., and M. Lecuit. 1998. Interactions of Listeria monocytogenes with mammalian cells during entry and actin-based movement: bacterial factors, cellular ligands and signaling. EMBO J. 17:3797-3806[Medline]. |
| 10. | Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387-395. |
| 11. | Gaillard, J. L., P. Berche, J. Mounier, S. Richard, and P. Sansonetti. 1987. Penetration of Listeria monocytogenes into the host: a crucial step of the infectious process. Ann. Inst. Pasteur Microbiol. 138:259-264. |
| 12. | Ireton, K., and P. Cossart. 1997. Host-pathogen interactions during entry and actin-based movement of Listeria monocytogenes. Annu. Rev. Genet. 31:113-138[Medline]. |
| 13. |
Jin, D. J., and C. A. Gross.
1989.
Characterization of the pleiotropic phenotypes of rifampin-resistant rpoB mutants of Escherichia coli.
J. Bacteriol.
171:5229-5231 |
| 14. | Kaufmann, S. H. E. 1991. Heat-shock proteins and pathogenesis of bacterial infections. Springer Semin. Immunopathol. 13:25-36[Medline]. |
| 15. | Lawson, P. A., S. E. Gharbia, H. N. Shah, and D. R. Clark. 1989. Recognition of Fusobacterium nucleatum subgroups FN-1, FN-2 and FN-3 by ribosomal RNA gene restriction patterns. FEMS Microbiol. Lett. 65:41-45. |
| 16. | Marron, L., N. Emerson, C. G. M. Gahan, and C. Hill. 1997. A mutant of Listeria monocytogenes LO28 unable to induce an acid tolerance response displays diminished virulence in a murine model. Appl. Environ. Microbiol. 63:4945-4947[Abstract]. |
| 17. | McDermot-Lancaster, D., and G. R. F. Hilson. 1987. Rifampin-resistant strains of Mycobacterium leprae may have reduced virulence. J. Med. Microbiol. 24:13-15. |
| 18. |
Mekalanos, J. J.
1992.
Environmental signals controlling expression of virulence determinants in bacteria.
J. Bacteriol.
174:1-7 |
| 19. |
Moorman, D. R., and G. L. Mandell.
1981.
Characterization of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus.
Antimicrob. Agents Chemother.
20:709-713 |
| 20. | O'Driscoll, B., C. G. M. Gahan, and C. Hill. 1996. Adaptive acid tolerance response in Listeria monocytogenes: isolation of an acid-tolerant mutant which demonstrates increased virulence. Appl. Environ. Microbiol. 62:1693-1698[Abstract]. |
| 21. |
Owens, J. T.,
R. Miyake,
K. Murakami,
A. J. Chmura,
N. Fujita,
A. Ishihama, and C. F. Meares.
1998.
Mapping the 70 subunit contact sites on Escherichia coli RNA polymerase with a 70-conjugated chemical protease.
Proc. Natl. Acad. Sci. USA
95:6021-6026 |
| 22. |
Portillo-Gomez, L.,
J. Nair,
D. A. Rouse, and S. L. Morris.
1995.
The absence of genetic markers for streptomycin and rifampin resistance in Mycobacterium avium complex strains.
J. Antimicrob. Chemother.
36:1049-1053 |
| 23. |
Portnoy, D. A.,
T. Chakraborty,
W. Goebel, and P. Cossart.
1992.
Molecular determinants of Listeria monocytogenes pathogenesis.
Infect. Immun.
60:1263-1267 |
| 24. |
Ripio, M.-T.,
G. Dominguez-Bernal,
M. Lara,
M. Súarez, and J.-A. Vázquez-Boland.
1997.
A Gly145Ser substitution in the transcriptional activator PrfA causes constitutive overexpression of virulence factors in Listeria monocytogenes.
J. Bacteriol.
179:1533-1540 |
| 25. |
Tanaka, K.,
S. Kusano,
N. Fujita,
A. Ishihama, and H. Takahasi.
1995.
Promoter determinants for Escherichia coli RNA polymerase holoenzyme containing 38 (the rpoS gene product).
Nucleic Acids Res.
23:827-834 |
| 26. |
Tribuddharat, C., and M. Fennewald.
1999.
Integron-mediated rifampin resistance in Pseudomonas aeruginosa.
Antimicrob. Agents Chemother.
43:960-962 |
| 27. | Van Langendonck, N., E. Bottreau, S. Bailly, M. Tabouret, J. Marly, P. Pardon, and P. Velge. 1998. Tissue culture assays using Caco-2 cell line differentiate virulent from non-virulent Listeria monocytogenes strains. J. Appl. Microbiol. 85:337-346[Medline]. |
| 28. | Virji, M., S. M. Watt, S. Barker, K. Makepeace, and R. Doyonnas. 1996. The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol. Microbiol. 22:929-949[Medline]. |
| 29. | Ward, J. E., and J. Lutkenhaus. 1985. Overproduction of FtsZ induces minicell formation in Escherichia coli. Cell 42:941-949[Medline]. |
| 30. | Wehrli, W. 1983. Rifampin: mechanisms of action and resistance. Rev. Infect. Dis. 5:407-411. |
| 31. |
Wiedmann, M.,
T. J. Arvik,
R. J. Hurley, and K. J. Boor.
1998.
General stress transcription factor B and its role in acid tolerance and virulence of Listeria monocytogenes.
J. Bacteriol.
180:3650-3656 |
| 32. |
Wu, Q.-L.,
D. Kong,
K. Lam, and R. N. Husson.
1997.
A mycobacterial extracytoplasmic function sigma factor involved in survival following stress.
J. Bacteriol.
179:2922-2929 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»